Cargando…

Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study

End-stage renal disease patients on haemodialysis (HD) have been largely excluded from SARS-CoV-2 vaccine trials due to safety reasons and shown to mount lower responses to vaccination. This study aims to evaluate the immunogenicity and safety of inactivated COVID-19 vaccine among HD patients compar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puspitasari, Metalia, Sattwika, Prenali D., Rahari, Dzerlina S., Wijaya, Wynne, Hidayat, Auliana R. P., Kertia, Nyoman, Purwanto, Bambang, Thobari, Jarir At
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354113/ https://www.ncbi.nlm.nih.gov/pubmed/37463975 http://dx.doi.org/10.1038/s41598-023-38628-2

Ejemplares similares

Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis
por: Puspitasari, Metalia, et al.
Publicado: (2023)

Immunogenicity and safety of COVID-19 BNT162b2 booster vaccine in end-stage kidney disease patients receiving haemodialysis in Yogyakarta, Indonesia: a cohort prospective study
por: Puspitasari, Metalia, et al.
Publicado: (2023)

Right‐sided infective endocarditis in patients with uncorrected ventricular septal defect and patent ductus arteriosus: Two case reports
por: Sattwika, Prenali Dwisthi, et al.
Publicado: (2018)

Psychometric properties of kidney disease quality of life-36 (KDQOL-36) in dialysis patients in Indonesia
por: Rokhman, M. Rifqi, et al.
Publicado: (2022)

Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
por: Nurpeisova, Ainur, et al.
Publicado: (2022)

The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
por: Yang, Lei, et al.
Publicado: (2023)

Cytokines in gingivocrevicular fluid of rheumatoid arthritis patients: A review of the literature
por: Rahajoe, Poerwati S., et al.
Publicado: (2019)

Improving patient safety in haemodialysis
por: Bray, Benjamin D., et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Two Chemotherapy Regiments FAC vs. Taxane for Operable Breast Cancer Patients in Indonesia
por: Saptaningsih, Agusdini Banun, et al.
Publicado: (2022)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Safety and immunogenicity of an inactivated thimerosal‐free influenza vaccine in infants and children
por: Nolan, Terry, et al.
Publicado: (2009)

The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity
por: Keshtkar-Jahromi, Maryam, et al.
Publicado: (2020)

Persistent Left Superior Vena Cava Identified After Hemodialysis Catheter Insertion: A Case Report
por: Puspitasari, Metalia, et al.
Publicado: (2020)

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)
por: Cowley, Daniel, et al.
Publicado: (2019)

Safety, Immunogenicity and Duration of Immunity Elicited by an Inactivated Bovine Ephemeral Fever Vaccine
por: Aziz-Boaron, Orly, et al.
Publicado: (2013)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
por: Mo, Zhaojun, et al.
Publicado: (2017)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants
por: Gao, Shuyu, et al.
Publicado: (2022)

The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients
por: Yang, Lei, et al.
Publicado: (2023)

Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep
por: Matsiela, Matome Selina, et al.
Publicado: (2023)

Growth evaluation of several types of energy crops from tropical shrubs species
por: Susanto, Dwi, et al.
Publicado: (2019)

Paper-Based Electrochemical Biosensors for Food Safety Analysis
por: Kuswandi, Bambang, et al.
Publicado: (2022)

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study
por: Zeng, Huiqiong, et al.
Publicado: (2022)

Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
por: Zhou, Jun, et al.
Publicado: (2005)

Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
por: Han, Xiaoxu, et al.
Publicado: (2022)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
por: Li, Tong, et al.
Publicado: (2022)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023)

A Complicated Case of Diffuse Large B-Cell Lymphoma in an Elderly Presenting with Massive Gastrointestinal Bleeding Successfully Treated with R-mini CHOP
por: Sunggoro, Agus Jati, et al.
Publicado: (2021)

Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine
por: Montalban, Cecilia, et al.
Publicado: (2017)

Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus
por: So, Ho, et al.
Publicado: (2022)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
por: Matveeva, Irina, et al.
Publicado: (2022)

Implementation of a quality and safety checklist for haemodialysis sessions
por: Marcelli, Daniele, et al.
Publicado: (2015)

Increased IgA anti‐citrullinated protein antibodies in the periodontal inflammatory exudate of healthy individuals compared to rheumatoid arthritis patients
por: Rahajoe, Poerwati Soetji, et al.
Publicado: (2020)

Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
por: Harahap, Yahdiana, et al.
Publicado: (2020)

Efficacy and safety of convalescent plasma therapy in patients with moderate-to-severe COVID-19: A non-randomized comparative study with historical control in a referral hospital in Indonesia
por: Kurnianda, Johan, et al.
Publicado: (2022)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Complete Remission of Relapsed Hodgkin's Lymphoma following Brentuximab Vedotin and Gemcitabine Combination Therapy with Severe Hypotension as Possible Treatment-Related Adverse Event: A Case Report
por: Purwanto, Ibnu, et al.
Publicado: (2020)

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
por: Beran, Jiří, et al.
Publicado: (2013)

The Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccination: A Study of Maternal-Cord Blood Pairs in Taiwan
por: Lin, Shin-Yu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cs2f0njhhb8balqvbd1vg8jvds